Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Statistics

Total Valuation

HKG:2637 has a market cap or net worth of HKD 17.30 billion. The enterprise value is 15.94 billion.

Market Cap	17.30B
Enterprise Value	15.94B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2637 has 78.71 million shares outstanding.

Current Share Class	78.71M
Shares Outstanding	78.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.80%
Owned by Institutions (%)	6.04%
Float	14.27M

Valuation Ratios

The trailing PE ratio is 77.55 and the forward PE ratio is 79.95.

PE Ratio	77.55
Forward PE	79.95
PS Ratio	26.70
PB Ratio	9.75
P/TBV Ratio	9.76
P/FCF Ratio	135.08
P/OCF Ratio	97.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 71.64, with an EV/FCF ratio of 124.47.

EV / Earnings	80.92
EV / Sales	24.60
EV / EBITDA	71.64
EV / EBIT	74.51
EV / FCF	124.47

Financial Position

The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.07.

Current Ratio	6.31
Quick Ratio	6.06
Debt / Equity	0.07
Debt / EBITDA	0.55
Debt / FCF	0.96
Interest Coverage	33.52

Financial Efficiency

Return on equity (ROE) is 16.58% and return on invested capital (ROIC) is 49.21%.

Return on Equity (ROE)	16.58%
Return on Assets (ROA)	9.23%
Return on Invested Capital (ROIC)	49.21%
Return on Capital Employed (ROCE)	11.88%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	164
Asset Turnover	0.45
Inventory Turnover	2.12

Taxes

In the past 12 months, HKG:2637 has paid 23.42 million in taxes.

Income Tax	23.42M
Effective Tax Rate	10.63%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	188.51
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.67
Average Volume (20 Days)	486,606

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2637 had revenue of HKD 648.05 million and earned 197.00 million in profits. Earnings per share was 2.83.

Revenue	648.05M
Gross Profit	540.33M
Operating Income	213.95M
Pretax Income	220.42M
Net Income	197.00M
EBITDA	220.22M
EBIT	213.95M
Earnings Per Share (EPS)	2.83

Balance Sheet

The company has 1.48 billion in cash and 122.57 million in debt, with a net cash position of 1.36 billion or 17.25 per share.

Cash & Cash Equivalents	1.48B
Total Debt	122.57M
Net Cash	1.36B
Net Cash Per Share	17.25
Equity (Book Value)	1.77B
Book Value Per Share	22.53
Working Capital	1.35B

Cash Flow

In the last 12 months, operating cash flow was 177.92 million and capital expenditures -49.84 million, giving a free cash flow of 128.07 million.

Operating Cash Flow	177.92M
Capital Expenditures	-49.84M
Depreciation & Amortization	3.37M
Net Borrowing	n/a
Free Cash Flow	128.07M
FCF Per Share	1.63

Margins

Gross margin is 83.38%, with operating and profit margins of 33.01% and 30.40%.

Gross Margin	83.38%
Operating Margin	33.01%
Pretax Margin	34.01%
Profit Margin	30.40%
EBITDA Margin	33.98%
EBIT Margin	33.01%
FCF Margin	19.76%

Dividends & Yields

HKG:2637 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.14%
FCF Yield	0.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2637 has an Altman Z-Score of 23.3 and a Piotroski F-Score of 3.

Altman Z-Score	23.3
Piotroski F-Score	3